BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15998711)

  • 1. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
    Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
    Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Hamanaka I; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Endocrinology; 2004 Feb; 145(2):951-8. PubMed ID: 14592959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A.
    Zhang Q; Saito Y; Naya N; Imagawa K; Somekawa S; Kawata H; Takeda Y; Uemura S; Kishimoto I; Nakao K
    Hypertens Res; 2008 Jun; 31(6):1251-6. PubMed ID: 18716375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.
    Ellmers LJ; Knowles JW; Kim HS; Smithies O; Maeda N; Cameron VA
    Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H707-14. PubMed ID: 12124219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
    Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
    Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmitral inflow pattern assessed by Doppler echocardiography in angiotensin II type 1A receptor knockout mice with myocardial infarction.
    Nakamura Y; Yoshiyama M; Omura T; Yoshida K; Kim S; Takeuchi K; Iwao H; Yoshikawa J
    Circ J; 2002 Feb; 66(2):192-6. PubMed ID: 11999647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.
    Patel JB; Valencik ML; Pritchett AM; Burnett JC; McDonald JA; Redfield MM
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H777-84. PubMed ID: 15778276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides buffer renin-dependent hypertension.
    Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.
    Ogawa Y; Tamura N; Chusho H; Nakao K
    Can J Physiol Pharmacol; 2001 Aug; 79(8):723-9. PubMed ID: 11558681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.
    Yoshihara F; Tokudome T; Kishimoto I; Otani K; Kuwabara A; Horio T; Kawano Y; Kangawa K
    Clin Exp Nephrol; 2015 Apr; 19(2):197-207. PubMed ID: 24845230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor.
    Bridgman P; Aronovitz MA; Kakkar R; Oliverio MI; Coffman TM; Rand WM; Konstam MA; Mendelsohn ME; Patten RD
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H586-92. PubMed ID: 15764682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations.
    Bryan PM; Xu X; Dickey DM; Chen Y; Potter LR
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1636-44. PubMed ID: 17264312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
    Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
    Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation.
    Takahashi N; Saito Y; Kuwahara K; Harada M; Kishimoto I; Ogawa Y; Kawakami R; Nakagawa Y; Nakanishi M; Nakao K
    Hypertens Res; 2003 Oct; 26(10):847-53. PubMed ID: 14621189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
    Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
    J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
    Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
    Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.